A double-blind trial of 2% aspirin ointment was performed with 40 patients with painful diseases of the oral mucosa. At the beginning of treatment, patients received a medication case containing either the 2% aspirin ointment or placebo paste. The patients were allowed to apply the medicine to themselves whenever spontaneous pain in a lesion increased. This preparation provided a topically external use in the oral cavity, and the total dosage of aspirin in paste amounted to 6-30 mg per day, which was much lower than that had been generally administered. This study drug was thus expected to avoid side effects such as peptic ulcers detected after orally prescribed dosage of aspirin. Efficacy was assessed according to the standardization of evaluation of analgesics efficacy published in 1990. Outcomes for the patients receiving the 2% aspirin ointment were superior especially on rapidity of the effect. Most patients treated with 2% aspirin ointment adhered to the prescribed regimen, and no side effects were reported. Group differences for most criteria for efficacy were statistically significant. It was concluded that the 2% aspirin ointment gave such prompt alleviation of pain associated with oral mucous ulcers that had never been reported to date.
Introduction
Aspirinshas been widely prescribed for clinical use. A new ointment that is a 2% aspirin was developed at our hospital in 1988 and exerted effective analgesia in the treatment for postherpetic neuralgia1 and rheumatalgia arthritie. Since it has been improved for external use in the oral cavity, we suggested that it might have lenitive effect for treating painful diseases of the oral mucosa5-7). The efficacy of this ointment for the relief of oral mucous membrane pain was thus assessed in this study.
Patients, Materials and Methods
The investigation was initiated as a double-blind, vehicle controlled study to evaluate tolerance and efficacy of topically applied 2% aspirin ointment. Forty patients, ten males and thirty females, between eighteen and seventy five years of age, treated at Department of Oral Surgery, Branch
Hospital, the University of Tokyo between December 1993 and August 1994 for above pain were the subjects. The patients had to be above eighteen years old and have normal ability for pain assessment.
Patients who were hypersensitive to any non steroidal anti-inflammatory drugs (NSAIDs), using other
NSAIDs for the oral disease or having other complicated diseases within one week before the start of the investigation were excluded. or "no effect" (Table  10) 
Discussion
Recent studies point out a new conception called drug delivery system: D.D.S., a proper dose should be delivered to a lesional area without fail on account of an assurance that a drug therapeutic system includes both reliable efficacy and security9-11). Newly developed 2% aspirin ointment for external use was considered to avoid systemic side effects such as peptic ulcers detected following oral administration of aspirin-like drugs2,5-7). We thus conducted a double-blind study to assess the efficacy of this ointment for alleviation of pain associated with oral membranous ulcers.
Diseases of the oral mucosa arise from various causes and manifest a variety of the natures. Recent studies have suggested immunologic reactions to be importantly involved aphthous ulcers, There are three classes of aphthous ulcers that have been delineated minor, major, and herpetiform, The An analysis of variance (Mann-Whitney's U-test) revealed a significant group difference (p<0.05). 
